Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/tid.14408 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Orthopnea as a trigger for a diagnostic cascade of multiple infectious diseases.
IDCases
August 2025
Institute of Medical Microbiology, University Hospital Münster, Münster, Germany.
Background: Dyspnea is a common clinical symptom and cause of outpatient and inpatient presentations to the clinic. Diagnostic and therapeutic challenges appear, when additional diseases appear that are themselves associated with subjectively perceptible dyspnea. We report on a young woman with orthopnea as a trigger of a diagnostic cascade of various diseases.
View Article and Find Full Text PDFMapping the infectious burden in VEXAS syndrome: a systematic review and rationale for prevention.
Lancet Rheumatol
September 2025
Service de Médecine interne et polyvalente, Centre Hospitalier du Haut-Anjou, Château-Gontier, France; Université d'Angers, Inserm, CNRS, MITOVASC, Equipe MitoLab, SFR ICAT, F-49000 Angers, France. Electronic address:
Infections are increasingly recognised as a major cause of morbidity and mortality in patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome. We conducted a systematic review to characterise the infectious burden of VEXAS syndrome and propose preventive strategies. We included 57 studies (813 patients) showing that infections in patients with VEXAS syndrome were frequent, severe in 40-60% of cases, and fatal in 6-15% of cases.
View Article and Find Full Text PDFFour bispecific antibodies (BsAbs) are approved for the treatment of relapsed refractory multiple myeloma (RRMM), but their use is associated with infection risks, requiring mitigation strategies. This single-center retrospective study evaluated the incidence, etiology, and risk factors for infections in 158 RRMM patients treated with BsAbs. A total of 101 patients received BCMAxCD3 BsAbs (teclistamab and elranatamab), and 57 GPRC5DxCD3 BsAb (talquetamab).
View Article and Find Full Text PDFPopulation pharmacokinetics and Monte Carlo-based dosing optimization of trimethoprim-sulfamethoxazole.
Antimicrob Agents Chemother
September 2025
Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, China.
This study aimed to develop population pharmacokinetic (PopPK) models for intravenous sulfamethoxazole (SMX) and trimethoprim (TMP) to optimize dosing regimens for the treatment of pneumonia using these models. A prospective study was conducted in 79 patients treated with intravenous trimethoprim-sulfamethoxazole. PopPK models were developed using nonlinear mixed-effect modeling to evaluate the effects of liver function, kidney function, and genetic polymorphisms ( and ) on pharmacokinetic parameters.
View Article and Find Full Text PDFA prospective comparison of fungal load in paired sputum and bronchoalveolar lavage fluid for Pneumocystis pneumonia diagnosis: Clinical thresholds and diagnostic accuracy.
J Microbiol Immunol Infect
August 2025
Siriraj Integrative Center for Neglected Parasitic Diseases, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand. Electronic address:
Background: To compare diagnostic performances and accuracy of non-invasive specimens and bronchoalveolar lavage fluid (BALF) for diagnosing Pneumocystis pneumonia (PCP) in immunocompromised pneumonia patients.
Methods: A prospective study of 112 immunocompromised patients to evaluate P. jirovecii fungal loads in paired sputum and BALF from the same patients.